The service, called LillyDirect, comes on the back on extraordinary demand seen over the last year for powerful weight-loss drugs such as Novo Nordisk's Wegovy.
The obesity drug market, forecast to grow to about 100 billion USD by the end of the decade, has also attracted interest from weight management service providers WW International and Ro that have also launched telehealth services for the drugs.
Lilly said its direct-to-consumer service will also be available for patients with diabetes and migraine, with the website's pharmacy page listing migraine drug Emgality, insulin and similar products for home delivery.
